Rare diseases
Investigational molecules
Locations
Al. Tadeusza Kosciuszki 4, 90-419 Lodz, Poland
Research activity includes acute myeloid leukaemia and acute lymphoblastic leukemia, with interest in molecularly guided treatment, FLT3-mutated AML, CBF-AML, and JAK/STAT pathway-driven disease.
The sponsor’s oncology portfolio also reflects interest in combination treatment strategies for paediatric and adult leukaemia care.
Medical University Of Lodz runs clinical trials in conditions such as Nephrotic syndrome, Fabry's disease, Type IIa hyperlipidaemia, Type 1 diabetes mellitus, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome
PolandTitle: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease
PolandStudy on Inclisiran, Alirocumab, and Rosuvastatin for Children with Familial Hypercholesterolemia
PolandStudy on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes
PolandStudy on Dimethyl Fumarate for Patients with Mild Cognitive Impairment and Alzheimer's Disease
PolandStudy of Ruxolitinib and Chemotherapy Drug Combination for Children with Acute Lymphoblastic Leukemia and JAK/STAT Pathway Activation
PolandStudy Comparing Ustekinumab, Infliximab, and Combination Therapy for Patients with Moderate to Severe Ulcerative Colitis
PolandStudy on Personalized Treatment for Acute Myeloid Leukemia Using Cladribine, Daunorubicin, Cytarabine, and Drug Combinations for Specific Patient Groups
PolandStudy on the Effectiveness and Safety of Cyclosporine and Methotrexate for Children and Adolescents with Moderate to Severe Atopic Dermatitis
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
